Neylan John F.
CIK 0001640447 Name as filed on the most recent filing
Filed as Neylan John F. (32)
32 transaction lines · from 32 filings · filed 2015-08-14 to 2021-12-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
32 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-12-20 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 358 disposed | 2.62 | 938.00 | Form 4, filing 0001601485-21-000091 | |
| 2021-11-18 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 374 disposed | 4.13 | 1,544.62 | Form 4, filing 0001601485-21-000077 | |
| 2021-10-18 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 373 disposed | 8.62 | 3,215.26 | Form 4, filing 0001601485-21-000062 | |
| 2021-09-20 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 376 disposed | 10.07 | 3,786.32 | Form 4, filing 0001601485-21-000058 | |
| 2021-08-18 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 381 disposed | 9.03 | 3,440.43 | Form 4, filing 0001601485-21-000052 | |
| 2021-07-21 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 365 disposed | 10.98 | 4,007.70 | Form 4, filing 0001601485-21-000038 | |
| 2021-06-18 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 366 disposed | 13.20 | 4,831.20 | Form 4, filing 0001601485-21-000029 | |
| 2021-05-18 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 363 disposed | 13.91 | 5,049.33 | Form 4, filing 0001601485-21-000025 | |
| 2021-04-19 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 381 disposed | 13.55 | 5,162.55 | Form 4, filing 0001601485-21-000013 | |
| 2021-03-17 |
Angion Biomedica Corp. ANGN |
S, Open-market sale | 442 disposed | 19.13 | 8,455.46 | Form 4, filing 0001567619-21-006685 | |
| 2018-11-15 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,156 disposed | 2.77 | 3,202.12 | Form 4, filing 0001114220-18-000110 | |
| 2018-10-29 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,253 disposed | 3.07 | 3,846.71 | Form 4, filing 0001114220-18-000100 | |
| 2018-08-15 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,186 disposed | 3.04 | 3,605.44 | Form 4, filing 0001114220-18-000093 | |
| 2018-07-30 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,282 disposed | 3.86 | 4,948.52 | Form 4, filing 0001114220-18-000086 | |
| 2018-05-15 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,158 disposed | 5.69 | 6,589.02 | Form 4, filing 0001114220-18-000055 | |
| 2018-04-30 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,311 disposed | 4.67 | 6,122.37 | Form 4, filing 0001114220-18-000046 | |
| 2018-04-23 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,111 disposed | 4.59 | 5,099.49 | Form 4, filing 0001114220-18-000041 | |
| 2018-02-15 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 5,652 disposed | 4.81 | 27,186.12 | Form 4, filing 0001114220-18-000022 | |
| 2018-01-29 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,541 disposed | 4.81 | 7,412.21 | Form 4, filing 0001114220-18-000014 | |
| 2018-01-23 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,322 disposed | 4.92 | 6,504.24 | Form 4, filing 0001114220-18-000008 | |
| 2017-10-30 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,405 disposed | 6.03 | 8,472.15 | Form 4, filing 0001114220-17-000042 | |
| 2017-10-23 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,179 disposed | 6.53 | 7,698.87 | Form 4, filing 0001114220-17-000034 | |
| 2017-07-31 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,445 disposed | 7.14 | 10,317.30 | Form 4, filing 0001114220-17-000020 | |
| 2017-07-24 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,214 disposed | 7.27 | 8,825.78 | Form 4, filing 0001114220-17-000013 | |
| 2017-05-01 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,441 disposed | 5.97 | 8,602.77 | Form 4, filing 0000899243-17-011612 | |
| 2017-04-24 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,209 disposed | 5.73 | 6,927.57 | Form 4, filing 0000899243-17-010904 | |
| 2017-01-30 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 6,984 disposed | 4.65 | 32,475.60 | Form 4, filing 0000899243-17-002275 | |
| 2017-01-23 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,428 disposed | 5.39 | 7,696.92 | Form 4, filing 0000899243-17-001941 | |
| 2016-10-24 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,211 disposed | 4.72 | 5,715.92 | Form 4, filing 0000899243-16-032270 | |
| 2016-07-25 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 1,217 disposed | 7.43 | 9,042.31 | Form 4, filing 0000899243-16-025770 | |
| 2016-04-25 |
Keryx Biopharmaceuticals Inc KERX |
S, Open-market sale | 4,766 disposed | 5.21 | 24,830.86 | Form 4, filing 0000899243-16-018630 | |
| 2015-08-12 |
Keryx Biopharmaceuticals Inc KERX |
P, Open-market purchase | 10,000 acquired | 6.20 | 62,000.00 | Form 4, filing 0000899243-15-003121 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 31
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Neylan John F., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001640447
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6